Anthem Bioscienc

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0CZ201020
  • NSEID: ANTHEM
  • BSEID: 544449
INR
950.95
13.2 (1.41%)
BSENSE

Nov 20

BSE+NSE Vol: 3.82 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Ajanta Pharma
Gland Pharma
Emcure Pharma
Ipca Labs
Sai Life
Anthem Bioscienc
Glaxosmi. Pharma
Glenmark Pharma
Alkem Lab
Abbott India
Biocon
Why is Anthem Biosciences Ltd ?
1
High Management Efficiency with a high ROE of 19.24%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Healthy long term growth as Net Sales has grown by an annual rate of 21.40% and Operating profit at 33.23%
  • PBDIT(Q) Highest at Rs 271.49 cr.
  • OPERATING PROFIT TO NET SALES(Q) Highest at 45.70%
  • PBT LESS OI(Q) Highest at Rs 237.47 cr.
4
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 19-Nov-26 and has generated 1.27% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and DOW
5
With ROE of 19.2, it has a Very Expensive valuation with a 16.3 Price to Book Value
  • Over the past year, while the stock has generated a return of 46.80%, its profits have risen by 36%
6
Majority shareholders : Promoters
7
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
8
Market Beating Performance
  • The stock has generated a return of 46.80% in the last 1 year, much higher than market (BSE500) returns of 0.37%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Anthem Bioscienc should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Anthem Bioscienc for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Anthem Bioscienc
46.8%
1.60
29.25%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
21.40%
EBIT Growth (5y)
33.23%
EBIT to Interest (avg)
97.54
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
0.62
Tax Ratio
27.71%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
15.90%
ROCE (avg)
30.84%
ROE (avg)
19.24%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
85
Industry P/E
40
Price to Book Value
16.33
EV to EBIT
74.36
EV to EBITDA
62.52
EV to Capital Employed
20.23
EV to Sales
25.86
PEG Ratio
NA
Dividend Yield
0.21%
ROCE (Latest)
27.21%
ROE (Latest)
19.24%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
PBDIT(Q)

Highest at Rs 271.49 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 45.70%

PBT LESS OI(Q)

Highest at Rs 237.47 cr.

PAT(Q)

Highest at Rs 211.46 cr.

EPS(Q)

Highest at Rs 3.75

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Anthem Bioscienc
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 237.47 cr has Grown at 46.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 162.28 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 211.46 cr has Grown at 42.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 148.33 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 271.49 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 45.70%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 237.47 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 211.46 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 3.75
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Anthem Bioscienc
Non Operating Income - Quarterly
Highest at Rs 58.90 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income